2008 - Alteplase given 3 to 4.5 hours after stroke reduced disability and improved global outcome
- Alteplase improves stroke outcome up to 4.5 hours. Mayor, Susan // British Journal of Hospital Medicine (17508460);Nov2008, Vol. 69 Issue 11, p613
The article reports on the European Cooperative Acute Stroke Study (ECASS) on alteplase drug. It shows that thrombolysis with alteplase reduces the risk of patients with mild to moderate stroke when given within 4.5 hours of symptom onset. More specifically, patients treated with alteplase had a...
- Expanding thrombolysis to older adults, others could triple lives saved. // Geriatrics;Mar1993, Vol. 48 Issue 3, p22
The article reports on the expansion of the U.S. guidelines for thrombolytic therapy. Thrombolytic therapy for acute MI saves 7,200 U.S. lives per year and expanding its use to patients with a favorable risk-benefit ratio could triple the number of lives saved. The current eligibility criteria...
- Thrombolytic therapy in acute myocardial infarction. Tough, Jackie // Nursing Standard;5/25/2005, Vol. 19 Issue 37, p55
This article examines thrombolytic therapy, the first-line treatment for patients presenting with acute myocardial infarction in most UK hospitals. The pharmacology of thrombolytic drugs and reasons for their use are discussed.
- Cardiovascular system. // Nursing Standard;5/25/2005, Vol. 19 Issue 37, p66
Presents a question-and-answer quiz on the cardiovascular system. Thrombolytic drugs; Primary percutaneous coronary interventions.
- Antithrombotic Therapy for Acute Coronary Syndromes. Spinler, Sarah A.; Inverso, Stephanie M.; Dailey, Janet H.; Cziraky, Mark J. // Journal of the American Pharmacists Association: JAPhA;Mar/Apr2004 Supplement 1, Vol. 44, pS14
Objectives: To review the role of antithrombotic therapy for treatment of acute coronary syndromes (ACS) in the hospital setting. Data Sources: Recent (1995-2003) published scientific literature, as identified by the authors through Medline searches, using the terms acute coronary syndromes,...
- Thrombolysis in stroke: minutes mean mind. Lindsay, Alistair C.; Qureshi, Katie // Heart;Jan2009, Vol. 95 Issue 1, p93
The article reports on the study conducted by the European Cooperative Acute Stroke about thromolysis in stroke. It is designed to test the hypothesis that alteplase administered in patients with acute ischaemic stroke. The study's limitations include the small numbers of diabetic patients...
- Therapeutic thrombolysis for acute ischaemic stroke. Warlow, Charles; Wardlaw, Joanna // BMJ: British Medical Journal (International Edition);2/1/2003, Vol. 326 Issue 7383, p233
Discusses the use of therapeutic thrombolysis for acute ischaemic stroke. Practice used for heart attacks that should not be used for brain attacks; Difference between heart attacks and brain attacks; Belief that certain studies require more information; Licensing of recombinant tissue...
- Local Thrombolysis and Percutaneous Transluminal Venoplasty for the Venous Complications of Thoracic Outlet Syndrome: Case Report. Baron, Bruce; Kiproff, Paul M.; Khoury, Maroon B. // Angiology;Nov1992, Vol. 43 Issue 11, p957
The authors report successful treatment of a case proven to result from the thoracic outlet syndrome by local fibrinolytic therapy with urokinase followed by percutaneous transluminal venoplasty.
- Rapid Neurological Recovery Post Thrombolysis: Mechanisms and Implications. Machumpurath, Bejoy; Reddy, Maya; Yan, Bernard // Neuroscience & Medicine;Mar2013, Vol. 4 Issue 1, p36
Intravenous thrombolysis improves long term functional outcomes in acute ischemic stroke. A select proportion of patients treated with thrombolysis experience rapid early neurological recovery, a powerful predictor of favourable long term outcomes. There is increased interest to augment early...